MX2019000384A - Metodo para producir una forma polimorfica de 3-[5-amino-4-(3-cianobenzoilo)-pirazol-1-il]-n-ciclopropil-4-meti lbenzamida. - Google Patents
Metodo para producir una forma polimorfica de 3-[5-amino-4-(3-cianobenzoilo)-pirazol-1-il]-n-ciclopropil-4-meti lbenzamida.Info
- Publication number
- MX2019000384A MX2019000384A MX2019000384A MX2019000384A MX2019000384A MX 2019000384 A MX2019000384 A MX 2019000384A MX 2019000384 A MX2019000384 A MX 2019000384A MX 2019000384 A MX2019000384 A MX 2019000384A MX 2019000384 A MX2019000384 A MX 2019000384A
- Authority
- MX
- Mexico
- Prior art keywords
- pyrazol
- amino
- methylbenzamide
- cyclopropyl
- cyanob
- Prior art date
Links
- VGUSQKZDZHAAEE-UHFFFAOYSA-N 3-[5-amino-4-(3-cyanobenzoyl)pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide Chemical compound CC1=CC=C(C(=O)NC2CC2)C=C1N(C=1N)N=CC=1C(=O)C1=CC=CC(C#N)=C1 VGUSQKZDZHAAEE-UHFFFAOYSA-N 0.000 title abstract 2
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 abstract 2
- -1 3-cyanobenzoyl Chemical group 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/14—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D231/38—Nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
Esta invención se refiere a un proceso para la preparación de la Forma B de 3-[5-amino-4-(3-cianobenzoil)pirazol-1-iI]-N-ciclopropi l-4-metilbenzamida. En la presente también se describe la Forma B de 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il]-N-ciclopropil-4-met ilbenzamida, o composiciones farmacéuticas de la misma, que se pueden obtener mediante el procedimiento descrito en la presente.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1612238.4A GB201612238D0 (en) | 2016-07-14 | 2016-07-14 | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-Yl]-n-cyclopropyl-4-methylbenzamide |
| PCT/GB2017/052055 WO2018011578A1 (en) | 2016-07-14 | 2017-07-13 | Method for producing a polymorphic form of 3-[5-amino-4-(3-cyanobenzoyl)-pyrazol-1-yl]-n-cyclopropyl-4-methylbenzamide |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2019000384A true MX2019000384A (es) | 2019-05-23 |
| MX379452B MX379452B (es) | 2025-03-10 |
Family
ID=56890595
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2019000384A MX379452B (es) | 2016-07-14 | 2017-07-13 | Método para producir una forma polimórfica de 3-[5-amino-4-(3-cianobenzoilo)-pirazol-1-il]-n-ciclopropil-4-metilbenzamida. |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US10995071B2 (es) |
| EP (1) | EP3484853B9 (es) |
| JP (1) | JP7094020B2 (es) |
| KR (1) | KR102460533B1 (es) |
| CN (1) | CN109415325B (es) |
| AU (1) | AU2017294642B2 (es) |
| CA (1) | CA3030617C (es) |
| DK (1) | DK3484853T5 (es) |
| ES (1) | ES2879608T3 (es) |
| GB (1) | GB201612238D0 (es) |
| HU (1) | HUE054686T2 (es) |
| IL (1) | IL263900B (es) |
| MX (1) | MX379452B (es) |
| PL (1) | PL3484853T3 (es) |
| PT (1) | PT3484853T (es) |
| RU (1) | RU2765719C2 (es) |
| SG (1) | SG11201811517SA (es) |
| WO (1) | WO2018011578A1 (es) |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100404256B1 (ko) | 1998-05-05 | 2003-11-01 | 에프. 호프만-라 로슈 아게 | 피-38 엠에이피 키나제 저해제로서의 피라졸 유도체 |
| PT1641764E (pt) | 2003-06-26 | 2011-10-27 | Novartis Ag | Inibidores de p38 quinase a base de heterociclo de 5 elementos |
| AU2013237503B2 (en) | 2012-03-20 | 2016-05-26 | Mereo Biopharma 1 Limited | Use of a pyrazole derivative in the treatment of acute exacerbations of chronic obstructive pulmonary disease |
| KR20180119597A (ko) | 2016-03-08 | 2018-11-02 | 메레오 바이오파마 1 리미티드 | 염증 상태의 급성 악화의 치료를 위한 투약법 |
| CA3016488C (en) | 2016-03-08 | 2023-04-11 | Mereo Biopharma 1 Limited | Dosage regimen for the treatment of acute exacerbations of chronic obstructive pulmonary disease |
-
2016
- 2016-07-14 GB GBGB1612238.4A patent/GB201612238D0/en not_active Ceased
-
2017
- 2017-07-13 ES ES17742277T patent/ES2879608T3/es active Active
- 2017-07-13 HU HUE17742277A patent/HUE054686T2/hu unknown
- 2017-07-13 CN CN201780041115.7A patent/CN109415325B/zh active Active
- 2017-07-13 SG SG11201811517SA patent/SG11201811517SA/en unknown
- 2017-07-13 AU AU2017294642A patent/AU2017294642B2/en active Active
- 2017-07-13 WO PCT/GB2017/052055 patent/WO2018011578A1/en not_active Ceased
- 2017-07-13 DK DK17742277.1T patent/DK3484853T5/da active
- 2017-07-13 KR KR1020197001013A patent/KR102460533B1/ko active Active
- 2017-07-13 RU RU2019103879A patent/RU2765719C2/ru active
- 2017-07-13 US US16/317,014 patent/US10995071B2/en active Active
- 2017-07-13 EP EP17742277.1A patent/EP3484853B9/en active Active
- 2017-07-13 JP JP2019501449A patent/JP7094020B2/ja active Active
- 2017-07-13 PL PL17742277T patent/PL3484853T3/pl unknown
- 2017-07-13 CA CA3030617A patent/CA3030617C/en active Active
- 2017-07-13 MX MX2019000384A patent/MX379452B/es unknown
- 2017-07-13 PT PT177422771T patent/PT3484853T/pt unknown
-
2018
- 2018-12-23 IL IL263900A patent/IL263900B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR102460533B1 (ko) | 2022-10-31 |
| AU2017294642A1 (en) | 2019-01-17 |
| WO2018011578A1 (en) | 2018-01-18 |
| RU2019103879A (ru) | 2020-08-14 |
| CA3030617A1 (en) | 2018-01-18 |
| JP2019521133A (ja) | 2019-07-25 |
| IL263900A (en) | 2019-01-31 |
| RU2765719C2 (ru) | 2022-02-02 |
| RU2019103879A3 (es) | 2020-08-14 |
| US10995071B2 (en) | 2021-05-04 |
| PL3484853T3 (pl) | 2021-11-02 |
| KR20190027819A (ko) | 2019-03-15 |
| CN109415325B (zh) | 2022-04-01 |
| EP3484853A1 (en) | 2019-05-22 |
| BR112019000540A2 (pt) | 2019-04-24 |
| AU2017294642B2 (en) | 2021-03-04 |
| IL263900B (en) | 2022-04-01 |
| SG11201811517SA (en) | 2019-01-30 |
| JP7094020B2 (ja) | 2022-07-01 |
| CN109415325A (zh) | 2019-03-01 |
| DK3484853T5 (da) | 2021-09-06 |
| ES2879608T3 (es) | 2021-11-22 |
| EP3484853B1 (en) | 2021-04-21 |
| MX379452B (es) | 2025-03-10 |
| HUE054686T2 (hu) | 2021-09-28 |
| DK3484853T3 (da) | 2021-05-25 |
| EP3484853B9 (en) | 2021-07-28 |
| GB201612238D0 (en) | 2016-08-31 |
| US20190315694A1 (en) | 2019-10-17 |
| PT3484853T (pt) | 2021-05-25 |
| CA3030617C (en) | 2024-02-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2021000630A1 (es) | Métodos para producir un anticuerpo anti-c5 (divisional de la solicitud no. 201701585) | |
| CL2020002277A1 (es) | Formas cristalinas de compuesto de triazolopirimidina (divisional 201803734) | |
| AR103992A1 (es) | Método para preparar compuestos fenólicos a partir de biomasa | |
| BR112017025873A2 (pt) | método para revestir a cabeça de um pirulito com um material de revestimento | |
| MX2020008507A (es) | Metodo para producir 1,1,3,3-tetracloropropeno. | |
| MX391448B (es) | Metodo para producir esteres de tetrahidropiranilo. | |
| CL2018002756A1 (es) | Un proceso mejorado para la preparación de tartrato de butorfanol. | |
| MX369857B (es) | Pirazinas moduladoras de receptor 6 acoplado a la proteina g (gpr6). | |
| MX2015015151A (es) | Metodo para producir 4-hidroxi-4-metil-tetrahidropiranos 2-sustituidos, donde dicho proceso usa reciclado. | |
| PL3445739T3 (pl) | Proces destylacji mieszaniny aldehydów | |
| MX2017011389A (es) | Proceso para la preparacion de 3-cloro-2-vinilfenilsulfonatos. | |
| MX2019004024A (es) | Metodo para preparar acetofenonas sustituidas con ciclopropilo. | |
| HUE070866T2 (hu) | Eljárás kalcium-magnézium-szulfonát kenõzsírok elõállítására | |
| ES2670477R1 (es) | Procedimiento para la preparacion de la 17beta-hidroxi-des-a-androst-9,10-en-5-ona | |
| MX389640B (es) | Método para producir dipropionato de calcio. | |
| MX382659B (es) | Proceso para la preparación de derivados de tiazol. | |
| BR112016023767A2 (pt) | forma sólida, composição farmacêutica, compostos, métodos, composições e utilizações | |
| IT201800011142A1 (it) | Forma per la produzione di calzature | |
| BR112018069255A2 (pt) | processos para a preparação de ácidos heteroaril carboxílicos | |
| MX2016015623A (es) | Proceso para la preparacion de derivados dihidroisoxazol. | |
| AR101951A1 (es) | Síntesis de ent-progesterona e intermediarios de la misma | |
| MX2016007864A (es) | Control de la formacion de cuerpos de color en la esterificacion de isohexida. | |
| BR112016030705B8 (pt) | Lipídeo de planta extraído e composição compreendendo o referido lipídeo | |
| MX2019000384A (es) | Metodo para producir una forma polimorfica de 3-[5-amino-4-(3-cianobenzoilo)-pirazol-1-il]-n-ciclopropil-4-meti lbenzamida. | |
| BR112019000460A2 (pt) | método para produzir uma forma polimórfica de 3-[5-amino-4-(3-cianobenzoil)-pirazol-1-il] -n-ciclopropil-4-metilbenzamida |